HER2 Support Group Forums - View Single Post

valleygirl · 01-02-2014, 04:43 PM

Hello all,

Can't decide between 2 trials. I'm eligible for both. The first is NCT01532960, pilot study of a breast cancer vaccine plus poly-ICLC for breast cancer the second is NCT01632332, Vaccine therapy in treating patients with previously treated stage ll-lll HER2 positive breast cancer.
I was hoping someone could explain the difference and if one would be better than the other. They're both phase 1 and seem to both be Peptide vaccines.

Thanks,
Denise

01-02-2014, 04:43 PM	#1
valleygirl Senior Member Join Date: Jan 2012 Location: Millsboro, Delaware Posts: 140	Trial help Hello all, Can't decide between 2 trials. I'm eligible for both. The first is NCT01532960, pilot study of a breast cancer vaccine plus poly-ICLC for breast cancer the second is NCT01632332, Vaccine therapy in treating patients with previously treated stage ll-lll HER2 positive breast cancer. I was hoping someone could explain the difference and if one would be better than the other. They're both phase 1 and seem to both be Peptide vaccines. Thanks, Denise